SPDR S&P Biotech ETF (XBI) options active amid FDA leadership headlines
Tweet
Share
E-mailSPDR S&P Biotech ETF (NYSE: XBI) 30-day option implied volatility is at 40; compared to its 52-week range of 24 to 62 amid FDA leadership headlines.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) gains nearly 6% as traders follow the money
- Analog Devices (ADI) call put ratio 1 call to 1.1 puts into quarter results
- Global debt issuance falls 16% in latest week, Goldman says
Create E-mail Alert Related Categories
OptionsRelated Entities
Standard & Poor's, Options, Maynard Um, Mark Zuckerberg, FDA, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
